Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...
50% of patients (3/6) with baseline HBsAg <1000 IU/mL achieved a functional cure (defined as sustained HBsAg loss and HBV DNA less than the lower limit of quantification (LLOQ) 24 weeks off all ...
Andrew Fein, an analyst from H.C. Wainwright, reiterated the Hold rating on Fulcrum Therapeutics (FULC – Research Report). The associated ...
A new device out of LSU can detect where cancer cells end and healthy tissues begin. Here's what it means for health outcomes ...
The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by Viatris an ...
Women have been speaking about pre-menstrual syndrome from decades, but could men be experiencing the same cycle? We asked ...
Doctors at Zuckerberg San Francisco General Hospital are using a cutting-edge AI tool to analyze medical scans, helping them ...
The Wilmington International Airport and Frontier Scientific Solutions announced a new project utilizing the first free trade ...
Vivos Therapeutics, Inc. ( NASDAQ: VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Kirk Huntsman - Chariman & CEO Brad Amman - CFO Scott Henry - Alliance Global Partners Lucas Ward ...
Violence alcohol - Nora de Bode considers a new review on the national and regional prevalence of interpersonal violence from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback